Pharma News, 2020

New York City's first confirmed COVID-19 cases stemmed primarily from European and United States sources, according to the first molecular epidemiology study of SARS-CoV-2 from researchers at the ...

(Reuters) - U.

AstraZeneca has secured approval from the US Food and Drug Administration (FDA) for its Brilinta (ticagrelor) to minimise the risk of a first heart attack or stroke in high-risk patien...

The U.

The FDA previously found low levels of NDMA in tested metformin that it said did not necessitate recalls.

NEW DELHI.

TAIPEI (Reuters) - Taiwan’s government said on Saturday it had approved Gilead Sciences’ potential COVID-19 treatment, remdesivir, to treat the illness caused by the novel coronavirus.

HONG KONG (Reuters) - A Chinese-made coronavirus vaccine could be ready for market as early as the end of this year, China’s State-owned Assets Supervision and Administration Commission (...

According to AstraZeneca, its EGFR inhibitor Tagrisso (osimertinib) has shown 'unprecedented disease-free survival' in the adjuvant treatment of patients with EGFR-mutated lung cancer.

The Committee recommended granting a marketing authorisation for a new vaccine that provides active immunisation to prevent Ebola virus disease in individuals aged one year and older.

NEW DELHI.

A team of computer scientists and pathologists have trained an artificial intelligence (AI) tool to identify lung cancer patients who have a higher risk of disease recurrence following treatme...